Abiopharma

Clinical trial NCT05877963 updates: 1. completion date: 2027-12-01 → 2027-01-21 2. primary completion date: 2027-12-01 → 2027-01-21

Clinical trial NCT07774000: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT06870162 updates: 1. completion date: 2026-06-30 → 2026-12-10 2. primary completion date: 2026-06-30 → 2026-12-10

Clinical trial NCT05156710: completion date: 2026-10-26 → 2026-10-20.

Clinical trial NCT07685769 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-17 → 2026-07-24 3. completion date: 2028-01-11 → 2028-01-04 4. primary completion date: 2028-01-11 → 2028-01-04

Clinical trial NCT04360941: status: RECRUITING → ACTIVE_NOT_RECRUITING.

Clinical trial NCT06549439 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-01 → 2026-06-30 3. enrollment: 10 → 7 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06751238 updates: 1. completion date: 2032-12-01 → 2031-03-11 2. primary completion date: 2032-11-30 → 2029-10-31

Clinical trial NCT05179369 updates: 1. completion date: 2026-06-30 → 2027-07-01 2. primary completion date: 2026-06-30 → 2027-06-01

Clinical trial NCT06053242 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-05-01 → 2027-08-20 3. primary completion date: 2026-05-01 → 2027-01-20

Clinical trial NCT04699123 updates: 1. completion date: 2025-06-30 → 2026-12-30 2. primary completion date: 2025-06-30 → 2026-12-30

Clinical trial NCT05944432 updates: 1. enrollment: 470 → 469 participants 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07335419: status: ACTIVE_NOT_RECRUITING → COMPLETED.

Clinical trial NCT05275218 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2025-12-01 → 2027-02-01 3. primary completion date: 2025-09-01 → 2026-02-09

Clinical trial NCT06823713: status: RECRUITING → ACTIVE_NOT_RECRUITING.